Personalized Treatment for Wherever You Are in Your Cancer Journey

The current standard of care for cancer has made great progress over the years, but it still relies on large population studies. That means treatment is based on what works for the “average” person, not what may work best for you.
Whether you’re newly diagnosed, seeking second opinions, or exploring options after treatment, we’re here to guide you.
Why First Ascent Biomedical?
We go beyond the standard of care by giving your doctor the most personalized insights available, tailored specifically to your cancer cells.
Personalized Treatment Insights – We analyze the unique characteristics of your solid or liquid cancer to identify the therapies most likely to work specifically for you.
Fewer Side Effects, Better Quality of Life – Avoid unnecessary treatments, side effects, and financial strain by focusing on what works.
More Options, More Hope – We uncover promising drug combinations—including newer or off-label treatments—and provide the data needed to support their use. Our technology has worked for all 52 cancer types it’s been used on and counting, which includes tumors and blood cancers.
Confidence Through Clarity – You’ll gain clear, actionable information about your cancer, so you and your care team can make informed decisions with confidence and peace of mind.
For more details, see our Frequently Asked Questions.
Our approach has shown up to 83% improvement in outcomes for patients with hard-to-treat or recurrent cancers
How It Works
We Work With Your Doctor Wherever You Are and Bring Clarity in 3 Simple Steps:
1. Start the Conversation
Connect with First Ascent or ask your oncologist to reach out to us directly through our contact form <crosslinks to: 7.0 Contact> or by calling 786‑746‑6722.
2. We Test Your Cancer
We take a sample of your own living cancer cells and test more than 150 FDA-approved drugs and combinations against it.
3. You Get Clear Answers
We aim to deliver a personalized, ranked report of the most effective drugs and combinations in 10 days, giving your doctor the clearest possible picture before making a care decision.
When doctors used our insights, 83% of patients responded to treatment. Only 13% of patients responded when doctors did not use our insights.
At 3 years old, Logan was diagnosed with a type of blood cancer called acute myeloid leukemia. He was treated with chemotherapy and had a bone marrow transplant, but 14 months later, his cancer came back. His doctor used the First Ascent platform to help guide his next treatment.
The test quickly showed which drug combination was most likely to help and which drugs weren’t needed. Logan started his new treatment plan right away. Now, more than 2 years later, Logan is still cancer-free.
Exploring Cost and Access
Several sponsored studies may help reduce or fully cover the cost for eligible participants. Explore the programs/studies below to learn whether you may qualify.
Pediatric Cancer
[Tile 1]
[Image – Nicklaus Children’s Hospital logo]
NIH funded 65 patient Functional Precision study with Nicklaus Children’s Hospital, Florida International university, and First Ascent Biomedical across all cancer types. Read more [LS1]
Adult Cancer
[Tile 2]
[Image – Cleveland Clinic logo]
36 patient funded functional precision medicine study with Cleveland Clinic Florida and Florida International University across all cancer types. Read more
[Tile 3]
[Image – Cleveland Clinic logo]
Florida is sponsoring free access to First Ascent Biomedical’s Functional Precision Oncology platform for 200 patients, across all cancer types enabling access to world-class care close to home. Read more > <links to: https://firstascentbiomedical.com/for-patients/florida-health/>
[Tile 4]
[Image – F!GHT Colorectal Cancer logo]
Fight Colorectal Cancer Foundation is sponsoring free access to the First Ascent’s leading edge cancer treatment platform for 35 Colorectal Cancer Patients. Read more > <links to: https://firstascentbiomedical.com/for-patients/fight-colorectal-cancer/>
[LS1]Suggestion for UX – Recommend redesigning w/out white button; follow website design guidelines
